CCCC Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - C4 Therapeutics Inc

Watchlist Manager

Watchlist

Price: 4.34 USD -7.07% Market Closed

Market Cap: $479.9m

	C4 Therapeutics Inc NASDAQ:CCCC	US
I	InnoTec TSS AG XMUN:TSS	DE
O	Otis Worldwide Corp F:4PG	US
	Lufax Holding Ltd F:0VU0	CN
	Aurelia Metals Ltd ASX:AMI	AU
	Sun International Ltd F:RY1B	ZA
S	Shiseido Co Ltd DUS:SHD	JP
E	Electricite de France SA F:E2F	FR
D	DoorDash Inc NASDAQ:DASH	US
F	Flowers Foods Inc F:FWF	US
F	Fisher & Paykel Healthcare Corporation Ltd ASX:FPH	NZ
	Rhoen Klinikum AG F:RHK	DE
	Prologis Inc NYSE:PLD	US
D	Daiichi Sankyo Co Ltd DUS:D4S	JP
C	Caterpillar Inc F:CAT1	US
F	Foot Locker Inc XMUN:WOO	US
A	Air China Ltd F:AD2	CN

Profitability Summary

C4 Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-291%

Negative 3Y Average Operating Margin

-485%

Operating Margin is Increasing

-902% > -291%

Negative Net Margin

-292%

Negative 3Y Average Net Margin

-459%

Net Margin is Increasing

-873% > -292%

Negative Free Cash Flow Margin

-276%

Negative 3Y Average Free Cash Flow Margin

-362%

Free Cash Flow Margin is Increasing

-718% > -276%

Negative ROE

-44%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-106%

ROIC is Increasing

-101% > -98%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.